Augmedix provided revenue guidance for the year 2024. The company expects to generate approximately $60 to $62 million of revenue in 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.16 USD | -4.13% | -50.43% | -80.17% |
May. 14 | Maxim Downgrades Augmedix to Hold From Buy | MT |
May. 14 | B. Riley Adjusts Price Target on Augmedix to $3 From $5.50, Keeps Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-80.17% | 56.54M | |
+15.73% | 70.77B | |
+5.46% | 17.14B | |
+12.50% | 13.82B | |
+19.02% | 13.49B | |
+15.17% | 10.06B | |
-17.72% | 7.24B | |
-1.01% | 6.18B | |
+3.17% | 5.26B | |
+0.45% | 5.03B |
- Stock Market
- Equities
- AUGX Stock
- News Augmedix, Inc.
- Augmedix Provides Revenue Guidance for the Year 2024